BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
2.060
+0.020 (0.98%)
Sep 5, 2025, 4:00 PM - Market closed
BioCardia Market Cap
BioCardia has a market cap or net worth of $11.95 million as of September 8, 2025. Its market cap has increased by 68.97% in one year.
Market Cap
11.95M
Enterprise Value
11.72M
1-Year Change
68.97%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $11.95M, a decrease of -58.90%. That is a compound annual growth rate of -9.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 11.95M | 19.58% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | 49.20M | 95.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |